Literature DB >> 5918151

Evidence for thyrocalcitonin in man.

G A Williams, G K Hargis, W B Galloway, W J Henderson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5918151     DOI: 10.3181/00379727-122-31380

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


× No keyword cloud information.
  6 in total

Review 1.  Calcitonin. A review of experimental and clinical investigations.

Authors:  G V Foster
Journal:  Postgrad Med J       Date:  1968-05       Impact factor: 2.401

2.  The rate of disappearance of infused calcium in idiopathic and post-thyroidectomy hypoparathyroidism before and during vitamin D treatment.

Authors:  G F Mazzuoli; I Antonozzi; G Coen
Journal:  Calcif Tissue Res       Date:  1968

3.  The syndrome of excessive thyrocalcitonin produced by medullary carcinoma of the thyroid.

Authors:  K E Melvin; A H Tashjian
Journal:  Proc Natl Acad Sci U S A       Date:  1968-04       Impact factor: 11.205

4.  Thyrocalcitonin.

Authors: 
Journal:  Br Med J       Date:  1967-07-29

5.  Thyrocalcitonin deficiency after treatment of thyroid disorders by surgery or radioiodine.

Authors:  R N Smith; H C Laljee
Journal:  Br Med J       Date:  1967-12-09

6.  Calcitonin receptor plays a physiological role to protect against hypercalcemia in mice.

Authors:  Rachel A Davey; Andrew G Turner; Julie F McManus; W S Maria Chiu; Francisca Tjahyono; Alison J Moore; Gerald J Atkins; Paul H Anderson; Cathy Ma; Vaida Glatt; Helen E MacLean; Cristina Vincent; Mary Bouxsein; Howard A Morris; David M Findlay; Jeffrey D Zajac
Journal:  J Bone Miner Res       Date:  2008-08       Impact factor: 6.741

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.